Steven I. Park

M.D., Lymphoma Program, Assistant Professor, School of Medicine, UNC-Chapel Hill, Clinical Research

Steven I. Park


Director of Lymphoma Program

Assistant Professor of Medicine

Leukemia, Lymphoma, and Myeloma Program

170 Manning Drive, CB#7305

Clinical profile

Area of interest

My research is primarily focused on targeted therapy for non-Hodgkin lymphoma. My group has examined various signaling pathways, including PI3K/mTOR and Myc, and their impact on the initiation and progression of lymphoma. We have also developed and validated a number of lymphoma xenograft and genetically-engineered mouse models for this project. In addition, we have performed translational research to identify novel anti-lymphoma compounds in these models. We hope this targeted approach against signaling pathways will enhance the efficacy of most traditional chemotherapeutics for treatment of lymphoma.

Awards and Honors

1996 - The Highest Distinction in General Scholarship, University of California, Berkeley

1999 - Deans Research Fellowship, University of California, Davis, School of Medicine

1999 - American Cancer Society Predoctoral Fellowship Award

2008 - Lymphoma Research Foundation Fellowship Award

2009 - Senior Fellow, University of Washington and Fred Hutchinson Cancer Research Center

2010 - KL2 - Interdisciplinary Clinical Research Career Development Award, NIH/UNC Clinical Translation Science Award (CTSA)

2012 - Center for AIDS Research Award

2014 - Center of Cancer Nanotechnology of Excellence Pilot Grant

2015 - American Cancer Society Mentored Research Scholar Grant (ACS-MRSG) Award in Applied and Clinical Research, Tumor Biology and Genomics 

Link to Publications on Reach NC site

Find publications on Pubmed